EMAIL THIS PAGE TO A FRIEND

The Journal of neuroscience : the official journal of the Society for Neuroscience

Frizzled3 Controls Axonal Polarity and Intermediate Target Entry during Striatal Pathway Development.


PMID 26490861

Abstract

The striatum is a large brain nucleus with an important role in the control of movement and emotions. Medium spiny neurons (MSNs) are striatal output neurons forming prominent descending axon tracts that target different brain nuclei. However, how MSN axon tracts in the forebrain develop remains poorly understood. Here, we implicate the Wnt binding receptor Frizzled3 in several uncharacterized aspects of MSN pathway formation [i.e., anterior-posterior guidance of MSN axons in the striatum and their subsequent growth into the globus pallidus (GP), an important (intermediate) target]. In Frizzled3 knock-out mice, MSN axons fail to extend along the anterior-posterior axis of the striatum, and many do not reach the GP. Wnt5a acts as an attractant for MSN axons in vitro, is expressed in a posterior high, anterior low gradient in the striatum, and Wnt5a knock-out mice phenocopy striatal anterior-posterior defects observed in Frizzled3 mutants. This suggests that Wnt5a controls anterior-posterior guidance of MSN axons through Frizzled3. Axons that reach the GP in Frizzled3 knock-out mice fail to enter this structure. Surprisingly, entry of MSN axons into the GP non-cell-autonomously requires Frizzled3, and our data suggest that GP entry may be contingent on the correct positioning of "corridor" guidepost cells for thalamocortical axons by Frizzled3. Together, these data dissect MSN pathway development and reveal (non)cell-autonomous roles for Frizzled3 in MSN axon guidance. Further, they are the first to identify a gene that provides anterior-posterior axon guidance in a large brain nucleus and link Frizzled3 to corridor cell development. Striatal axon pathways mediate complex physiological functions and are an important therapeutic target, underscoring the need to define how these connections are established. Remarkably, the molecular programs regulating striatal pathway development remain poorly characterized. Here, we determine the embryonic ontogeny of the two main striatal pathways (striatonigral and striatopallidal) and identify novel (non)cell-autonomous roles for the axon guidance receptor Frizzled3 in uncharacterized aspects of striatal pathway formation (i.e., anterior-posterior axon guidance in the striatum and axon entry into the globus pallidus). Further, our results link Frizzled3 to corridor guidepost cell development and suggest that an abnormal distribution of these cells has unexpected, widespread effects on the development of different axon tracts (i.e., striatal and thalamocortical axons).

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

468495
1,1′-Dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate, 97%
C59H97ClN2O4
42364
1,1′-Dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate, BioReagent, suitable for fluorescence, ≥98.0% (TLC)
C59H97ClN2O4
455830
Ammonium hydrogen difluoride, 99.999% trace metals basis
H5F2N
224820
Ammonium hydrogen difluoride, reagent grade, 95%
H5F2N
01110
Ammonium hydrogen difluoride, puriss., ≥97.5%
H5F2N
SAB4503329
Anti-DARPP-32 antibody produced in rabbit, affinity isolated antibody
HPA003876
Anti-FOXP1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
AV32564
Anti-FOXP1 antibody produced in rabbit, IgG fraction of antiserum
F3179 Anti-Frizzled-3 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB4503170
Anti-FZD3 antibody produced in rabbit, affinity isolated antibody
SAB4503171
Anti-FZD3 antibody produced in rabbit, affinity isolated antibody
SAB1407795
Anti-PCDH10 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA011220
Anti-PCDH10 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2106562
Anti-PCDH10 antibody produced in rabbit, affinity isolated antibody
SAB1408088
Anti-PPP1R1B antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA048630
Anti-PPP1R1B antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
WH0027086M1
Monoclonal Anti-FOXP1 antibody produced in mouse, clone 4E3-G11, purified immunoglobulin, buffered aqueous solution
WH0007976M9
Monoclonal Anti-FZD3 antibody produced in mouse, clone 2H5, purified immunoglobulin, buffered aqueous solution
SAB1404564
Monoclonal Anti-FZD3 antibody produced in mouse, clone 1B8, purified immunoglobulin, buffered aqueous solution
WH0057575M1
Monoclonal Anti-PCDH10 antibody produced in mouse, clone 4H8, purified immunoglobulin, buffered aqueous solution
SAB1405217
Monoclonal Anti-PCDH10 antibody produced in mouse, clone 2H6, purified immunoglobulin, buffered aqueous solution
SAB1403394
Monoclonal Anti-PPP1R1B antibody produced in mouse, clone 3G11, purified immunoglobulin, buffered aqueous solution
A4929
N,N′-Bis(acryloyl)cystamine, BioReagent, suitable for electrophoresis
C10H16N2O2S2